Patients with relapsing-remitting multiple sclerosis treated for two years with alemtuzumab demonstrated improved disease-related disability scores compared to patients who received treatment with subcutaneous interferon beta-1a.
Study results show that hip flexion weakness and, to a lesser extent, ankle dorsiflexion weakness have the greatest impact upon changes in walking speed as MS progresses
Data indicate patients with relapsing remitting multiple sclerosis (RRMS) treated with BG-12 (dimethyl fumarate) showed no clinical disease activity for up to two years.
Researchers reported the MMRV and separately administered MMR plus varicella vaccines were associated with a greater incidence of fever, seizures, and immune thrombocytopenia purpura seven to 10 days after vaccine administration.
The expected increase in high-deductible health plan (HDHP) enrollment due to implementation of the Affordable Care Act (ACA) highlights the need for more research into the health impact of HDHPs.
The shutdown of non-essential government services as of midnight Oct. 1 has led to questions about what the shutdown means for primary care physicians and their patients.
Problems navigating the new federal and state computer-based health insurance exchanges spilled into a third day Thursday.
Though roughly 14 percent of Parkinson’s disease patients seen in routine practice have diplopia, most have not discussed it with their physicians, according to a new study presented at the annual meeting of the World Congress of Neurology, held from September 21-26, 2013, in Vienna.
Demand for physicians, particularly primary care physicians remains high, according to a report published by the Association of Staff Physician Recruiters (ASPR).
The government shutdown is having a serious impact on health care agencies, according to an article published Oct. 1 in Medical Economics.